Patent details

EP3658156 Title: TELOMERASE INHIBITOR FOR USE IN TREATING A MYELODYSPLASTIC SYNDROME

Basic Information

Publication number:
EP3658156
PCT Application Number:
US2018044225
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187556089
PCT Publication Number:
WO2019023667
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TELOMERASE INHIBITOR FOR USE IN TREATING A MYELODYSPLASTIC SYNDROME
French Title of Invention:
INHIBITEUR DE LA TÉLOMÉRASE POUR LA TRAITEMENT D'UN SYNDROME MYÉLODYSPLASIQUE
German Title of Invention:
TELOMERASE HEMMER ZUR BEHANDLUNG EINES MYELODYSPLASTISCHEN SYNDROMS
SPC Number:

Dates

Filing date:
27/07/2018
Grant date:
25/03/2026
EP Publication Date:
03/06/2020
PCT Publication Date:
31/01/2019
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/03/2026
EP B1 Publication Date:
25/03/2026
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
27/07/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/03/2026
 
 

Name:
Geron Corporation
Address:
919 E. Hillsdale Blvd., Suite 250, Foster City, CA 94404, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
01/04/2026
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
BUSSOLARI, Jacqueline Cirillo
Address:
United States (US)

2

Name:
RIZO, Aleksandra
Address:
United States (US)

Priority

1

Priority Number:
201762538315 P
Priority Date:
28/07/2017
Priority Country:
United States (US)

2

Priority Number:
201762595329 P
Priority Date:
06/12/2017
Priority Country:
United States (US)

3

Priority Number:
201862685542 P
Priority Date:
15/06/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7125; A61P 7/00;

Publication

European Patent Bulletin

Issue number:
202613
Publication date:
25/03/2026
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2026 Power Of Attorney 1
01/04/2026 Outgoing Correspondence 1